Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Management of Deep Retinal Capillary Ischemia by Electromagnetic Stimulation and Platelet- Rich Plasma

Phase: N/A Priority: Normal
NCT ID: NCT04242719 Org: User:
Start: 01/01/18 End: 02/28/19 Due: 02/28/20

Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser

Phase: N/A Priority: Normal
NCT ID: NCT04234438 Org: User:
Start: 01/01/18 End: 12/30/19 Due: 12/30/20

Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa

Phase: N/A Priority: Normal
NCT ID: NCT04238858 Org: User:
Start: 09/01/16 End: 01/30/18 Due: 01/30/19

Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma

Phase: N/A Priority: Normal
NCT ID: NCT04252534 Org: User:
Start: 01/01/17 End: 12/30/19 Due: 12/30/20

Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells

Phase: N/A Priority: Normal
NCT ID: NCT04224207 Org: User:
Start: 04/01/19 End: 01/01/20 Due: 01/01/21

Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation

Phase: N/A Priority: Normal
NCT ID: NCT04877067 Org: User:
Start: 04/01/19 End: 04/30/21 Due: 04/30/22

Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision

Phase: N/A Priority: Normal
NCT ID: NCT05800301 Org: User:
Start: 01/01/19 End: 12/31/22 Due: 12/31/23

Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma

Phase: N/A Priority: Normal
NCT ID: NCT04224831 Org: User:
Start: 12/01/18 End: 01/01/20 Due: 01/01/21